Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast

Autor: Honig, Marcia G., Del Mar, Nobel A., Henderson, Desmond L., O'Neal, Dylan, Yammanur, Meghna, Cox, Rachel, Li, Chunyan, Perry, Aaron M., Moore, Bob M., Reiner, Anton
Zdroj: In Experimental Eye Research May 2022 218
Databáze: ScienceDirect